← Eichor
Condition: Hepatitis C Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepatitis C

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Phase N/A · 2 location(s) · MagIA Diagnostics · NCT07170748Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients
NA · 9 location(s) · Johns Hopkins University · NCT05653232The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset
Phase N/A · 12 location(s) · Kirby Institute · NCT05713136Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipien
Phase 2 · 3 location(s) · Baylor Research Institute · NCT03383419ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
NA · 32 location(s) · Kirby Institute · NCT03685045Screening of Patients With Hepatic Fibrosis or Cirrhosis B and C
NA · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06755632Effect of Some Drugs on Liver Fibrosis
Phase 3 · 1 location(s) · Sherief Abd-Elsalam · NCT03770936Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
NA · 1 location(s) · University of California, San Francisco · NCT06179498Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06544863Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of D
Phase N/A · 2 location(s) · University of Oxford · NCT06658782Persuasive Health Communication Intervention for HIV/HCV
NA · 1 location(s) · University of South Florida · NCT05968573Drug-Drug Intercations and Direct Acting Antiviral Agents Against HCV
Phase N/A · 4 location(s) · University of Seville · NCT06928259The Efficacy of Vosevi in Treating DAA-experienced Patients
Phase N/A · 1 location(s) · The Third Affiliated Hospital of Guangzhou Medical Universit · NCT06180590Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Canc
Phase N/A · 4 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06718530Hepatitis C Pharmacist, Physician, Patient Navigator Collaborative Care Model in Permanent Supportive Housing
NA · 1 location(s) · University of Washington · NCT07667101Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons
NA · 9 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT07122219Hepatitis C Tracker Study
NA · 2 location(s) · University of Southern California · NCT06870019The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Phase N/A · 1 location(s) · The Task Force for Global Health · NCT05368974Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan
Phase N/A · 1 location(s) · Kaohsiung Medical University Chung-Ho Memorial Hospital · NCT03200379Feasibility and Acceptability of HCV Treatment in Pregnancy
Phase N/A · 2 location(s) · Washington University School of Medicine · NCT06367465Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
Phase 2/Phase 3 · 1 location(s) · White River Junction Veterans Affairs Medical Center · NCT05637879Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT06904820Treatment as Prevention for Hepatitis C in Iceland
Phase N/A · 1 location(s) · Landspitali University Hospital · NCT02647879The National Australian HCV Point-of-Care Testing Program - Minimal Dataset
Phase N/A · 11 location(s) · Kirby Institute · NCT05248555Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria
Phase N/A · 1 location(s) · Vanessa Stadlbauer-Koellner, MD · NCT06834178Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania
EARLY_Phase 1 · 1 location(s) · Médecins du Monde · NCT06159504
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.